This inventor holds 150 USPTO granted patents and 39 published patent applications, plus 46 CIPO patents and 47 EPO patents, primarily in Plant Biotechnology (CPC class C12N15-8286). Top assignee: Monsanto Technology LLC. Active years: 2003-2026.
Inventors with similar research interests:
Location History:
- St. Louis, MO (US) (2016 - 2017)
- Chesterfield, MO (US) (2003 - 2024)
- Ballwin, MO (US) (2019 - 2024)
Company Filing History:
Years Active: 2003-2026
Areas of Expertise:
Title: Unveiling the Inventive Mind of Stanislaw Flasinski
Introduction:
Stanislaw Flasinski is an accomplished inventor based in Ballwin, MO (US), known for his groundbreaking work in the field of biotechnology. With eight patents to his name, he has significantly contributed to the realm of plant gene expression and insect control mechanisms.
Latest Patents:
Flasinski's recent patents demonstrate his expertise in the agricultural sector. One notable invention includes "Plant regulatory elements and uses thereof," which focuses on DNA molecules and constructs for modulating gene expression in plants. Another significant patent is "Proteins toxic to hemipteran insect species," highlighting his innovative approach to developing proteins for insect control in agricultural systems.
Career Highlights:
Flasinski is affiliated with Monsanto Technology LLC, a prominent company in the biotechnology industry. His tenure at Monsanto has been marked by numerous successes in patenting novel technologies that have the potential to revolutionize modern agriculture.
Collaborations:
Throughout his career, Flasinski has collaborated closely with industry experts such as James A. Baum and Arlene R. Howe. These collaborations have not only enriched his own work but have also led to the development of innovative solutions that benefit the agricultural community.
Conclusion:
In conclusion, Stanislaw Flasinski stands out as a visionary inventor whose pioneering work in biotechnology has had a profound impact on the agricultural landscape. With a passion for innovation and a drive to push the boundaries of scientific discovery, Flasinski continues to inspire others in the industry to strive for excellence and creativity in their pursuits.